Adrenal metastasectomy for oligometastatic non–small cell lung cancer in the era of immunotherapy and molecular-targeted therapy: outcomes and application of the ESTRO-EORTC oligometastatic classification in a single-institution surgical cohort

Coverage, in order

1. 9h ago
   Research Square obscure study observational

   Adrenal metastasectomy for oligometastatic non–small cell lung cancer in the era of immunotherapy and molecular-targeted therapy: outcomes and application of the ESTRO-EORTC oligometastatic classification in a single-institution surgical cohort

   Background Adrenal metastasectomy for non–small cell lung cancer (NSCLC) has been reported mainly in historical series, and the ESTRO-EORTC oligometastatic classification has rarely been applied to surgical cohorts. We evaluated contemporary outcomes and applied this classification to a…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.